India has raised the issue of pharmaceutical pricing control in Australia, particularly on generic medicines, during a bilateral meeting between the officials of both countries. The two sides have decided to work closely on resolving market access issues, enhancing people-to-people contacts, and establishing an institutional mechanism for sharing preferential import data.
The Indian government has announced that investments worth Rs. 25,813 crore have been made and 56,171 new jobs have been added under the production-linked incentive (PLI) scheme for pharmaceuticals. The scheme aims to enhance India’s manufacturing capabilities in the pharmaceutical sector and promote the production of high-value goods. Additionally, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana has successfully achieved its target of opening 10,000 retail outlets to provide affordable generic medicines to the poor and underprivileged.
